News

GEP Software Achieves Top Ranking in Spend Matters 2025 Review

GEP Software Achieves Top Ranking in Spend Matters 2025 Review

GEP Software Leads in Procurement Categories

GEP SOFTWARE has proudly been recognized as the top-performing solution suite in the Spend Matters Fall 2025 SolutionMap. This prestigious acknowledgment comes after GEP topped 15 distinct categories, including Source-to-Pay (S2P) and Source-to-Contract (S2C) suites. For the ninth time in a row, GEP has demonstrated exceptional capabilities, being rated highly for its innovation, functionality, and robust AI-driven features.

Recognizing GEP's Achievements

The evaluations conducted by Spend Matters encompassed over 115 software vendors, detailing their capabilities across intake and orchestration, analytics, sourcing, supplier and risk management. GEP outperformed its competitors, solidifying its position as a preeminent AI-driven platform tailored for procurement, supply chain, and sustainability.

Groundbreaking Innovations in GEP Software

According to Spend Matters, GEP's unmatched functional scope and customer satisfaction reinforce its leadership in unifying procurement processes. GEP's solution suite, especially its S2P and S2C offerings, offers clients an integrated analytics experience, streamlined workflows, and enhanced user engagement.

Key Areas of Recognition

GEP's performance in the Fall 2025 SolutionMap was noted for excelling in several critical areas:

  • Source-to-Pay (S2P) & Source-to-Contract (S2C): A comprehensive suite recognized for its spend analytics and supplier collaboration efficiency.
  • Intake & Orchestration: A pivotal tool for automating and streamlining procurement processes.
  • Spend & Procurement Analytics: A central platform for tracking supplier spending effectively.
  • Sourcing & Direct Sourcing: Notable for its advanced workflows and AI-enabled cost modeling.
  • Supplier & Risk Management: Highest platform scores for risk visibility and supplier onboarding.

Feedback from Spend Matters

As described in the report, Spend Matters stated, "GEP's Value Leader placements in the technically extensive SolutionMap illustrate its market dominance and leading innovation capabilities. These recognitions affirm GEP's ability to offer unparalleled value in the transformation of procurement and supply chains for enterprises globally." This solidifies GEP SOFTWARE as an indispensable resource for modern businesses looking to enhance their operations.

The Future of GEP SOFTWARE

GEP SOFTWARE integrates cutting-edge technologies to ensure that procurement and supply chain management remain robust and agile. With products like GEP SMART and GEP NEXXE, the company continues to innovate its AI-driven platforms for market challenges. GEP QUANTUM further empowers clients by integrating smart analytics and low-code capabilities into their financial and operational landscapes.

Commitment to Customer Satisfaction

Beyond technology, GEP has garnered accolades for its commitment to customer satisfaction and loyalty. The brand emphasizes user-friendly interfaces, seamless integration capabilities, and continuous service improvements. This customer-centric approach not only enhances user experiences but also ensures high levels of productivity across enterprise teams.

Frequently Asked Questions

What is GEP SOFTWARE?

GEP SOFTWARE offers AI-driven digital procurement and supply chain platforms that help enterprises enhance efficiency and competitiveness.

How does GEP rank in procurement solutions?

According to Spend Matters Fall 2025 SolutionMap, GEP ranks as a leader across multiple categories, showcasing its innovative capabilities.

What features does GEP offer for procurement?

GEP provides a comprehensive set of features including source-to-pay, contract management, supplier collaboration, and extensive analytics.

Is GEP suitable for global enterprises?

Yes, GEP SOFTWARE is designed for Fortune 500 and Global 2000 companies, offering scalable solutions for varied business needs.

How does GEP ensure customer satisfaction?

GEP focuses on intuitive design, seamless integration, and robust user support, constantly enhancing the user experience.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Knee Treatment with Overture's Latest System

Updated Category News Views 312

Full Commercial Launch of the OvertureTi Knee Resurfacing System Overture Orthopaedics is making headlines as it proudly announces the full commercial launch of its advanced OvertureTi Knee Resurfacing System. This medical device targets early osteoarthritis and cartilage defects effectively, presenting a breakthrough for patients seeking alternatives to traditional joint...

Continue Reading
Elis SA: Key Insights on Recent Share Buyback Activities

Updated Category News Views 130

Elis SA's Recent Share Buyback Activities Elis SA has made a mark with its recent trading activities associated with its own shares, particularly highlighting a series of transactions carried out during a specified period. Overview of the Buyback Program As part of its strategic financial planning, Elis has engaged in a buyback program that has garnered attention. The...

Continue Reading
Kevin O'Leary's Essential Advice for Startups on Content Investment

Updated Category News Views 262

O'Leary: Tools Are Cheap, But Talent Isn't Entrepreneur and "Shark Tank" star Kevin O'Leary emphasizes a critical insight for startups: while the cost of creating digital content has drastically reduced, the true value comes from the talent that produces it. O'Leary shared his thoughts in a recent video, indicating that although the cost of technology has significantly...

Continue Reading
The St. James Reinvents Lacrosse with Spencer Ford at the Helm

Updated Category News Views 237

The St. James Strengthens Lacrosse Initiatives In an exciting development, The St. James has appointed Spencer Ford as the new Director of Lacrosse, ushering in a transformative approach to lacrosse for both boys and girls. With a vast wealth of experience spanning nearly twenty years, Ford is not only a seasoned professional player but also an accomplished coach and...

Continue Reading
Hudbay Minerals Celebrates Permit Approval for Copper World

Updated Category News Views 119

Hudbay Minerals Receives Final Permit for Copper World Project Hudbay Minerals Inc. (TSX, NYSE: HBM), a prominent player in the mining industry, has taken a significant step forward by securing the final major permit necessary for its Copper World project in Arizona. This milestone not only enhances the company’s operational capacity but also solidifies its commitment...

Continue Reading